Leukemia, Myelodysplasia, Transplantation
News
Survival improves for AYAs with leukemia and lymphoma
However, their survival still lags behind survival in children.
Video
Ofatumumab
News
Overcoming limitations of haploidentical HSCT
Video
Allogeneic Stem Cell Transplant
Video
Mismatched Cord Blood
Video
Triple Therapy for CLL
News
Study shows imatinib response is durable and improves with time
SAN FRANCISCO—The longest duration study of imatinib treatment for patients with Ph+ CML shows 86% of patients are still alive 7 years after...